Specialized Veterinary Plasma Plasvacc USA specializes in hyper immunized equine and canine plasma products, with FDA/USDA-aligned quality and efficacy standards, presenting a niche for veterinary clinics and equine/canine treatment centers seeking high-antibody plasma options.

Global & Longstanding Experience Operating since 1996 with international usage, Plasvacc can leverage its legacy and regulatory compliance to win customers requiring proven track records, importer distributors, and cross-border supply partnerships.

Mid‑Market Growth Opportunity With 51–200 employees and revenue under $1M, there is potential to scale through partnerships with large veterinary distributors, clinics, and specialty hospitals looking to expand plasma product lines and import/export capabilities.

Regulatory & Quality Spotlight Emphasize adherence to USDA and APVMA guidelines to differentiate from competitors and target higher‑risk therapeutic indications in horses and dogs, appealing to practices prioritizing compliant, high‑quality biologics.

Digital & Channel Expansion Current tech stack includes Shopify and standard web tools; there is opportunity to enhance e‑commerce, B2B ordering, and distributor portals, plus content highlighting efficacy data to support sales outreach and self‑service purchasing.